NEUROPOINTDX
NeuroPointDX has developed a robust and reproducible proprietary platform for identifying changes in metabolism for diagnosis and more precise treatment of neurological disorders. These tests allow segmenting of complex neurological disorders, such as autism, into subtypes for earlier diagnosis and more precise treatment. They develop the diagnostic blood test for autism. In an NIH-funded clinical study, the children's autism metabolome project, the NPDX ASD test was validated.
NEUROPOINTDX
Industry:
Biotechnology Children Health Care Health Diagnostics
Founded:
2016-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.neuropointdx.com
Total Employee:
11+
Status:
Active
Contact:
+1 608 441 8187
Email Addresses:
[email protected]
Similar Organizations
Biosense Webster
Biosense Webster, Inc. is the global leader in the science of diagnosing and treating heart rhythm disorders.
Cognoptix
Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.
Plaxgen
Plaxgen Inc. is a biodiagnostics company with a unique diagnostic platform to personalized medicine.
SML Genetree
SML Genetree is a developer of diagnostic test solutions such as PCR Kits in the field of molecular biology.
Official Site Inspections
http://www.neuropointdx.com
- Host name: neuropointdx.com
- IP address: 199.101.49.63
- Location: Clifton Park United States
- Latitude: 42.8482
- Longitude: -73.7863
- Metro Code: 532
- Timezone: America/New_York
- Postal: 12065
More informations about "NeuroPointDX"
Autism Blood Test and Diagnosis for Children | NeuroPointDX.com
We improve the lives of children and families living with autism spectrum disorder (ASD) and other neurological disorders by providing tools for earlier diagnosis and more precise treatment. We …See details»
Read About Our Mission, Company, and Advisors
Learn more about NeuroPointDX’s mission and our company, and meet our leadership team of directors and advisors.See details»
Meet Our Distinguished Board of Directors
Our Board of Directors is comprised of industry leaders with the business acumen to lead us to the forefront of autism testing.See details»
NeuroPointDX - Crunchbase Company Profile & Funding
NeuroPointDX has developed a robust and reproducible proprietary platform for identifying changes in metabolism for diagnosis and more precise treatment of neurological disorders. …See details»
NeuroPointDX - Products, Competitors, Financials, Employees ...
NeuroPointDX is a company focused on the development of diagnostic tools for autism spectrum disorder (ASD) and other neurological disorders within the healthcare sector. Use the CB …See details»
Learn About Our Neurodevelopmental Division| stemina.com
NeuroPointDX is a business unit of Stemina that has created the NPDX ASD test, a new diagnostic tool for children with autism spectrum disorder.See details»
Stemina Biomarker appoints new Board member and prepares to ...
Oct 29, 2024 · Stemina, through its neurological disorders division, NeuroPointDX, is transforming diagnosis and more precise treatment of neurological disorders using its proprietary …See details»
Don M. Hardison - Director at NeuroPointDX - The Org
Don Hardison brings a broad private and public company background in both emerging and Fortune 500 companies. Mr. Hardison is currently President, CEO, and Director of …See details»
NeuroPointDx - Biotech Careers
NeuroPointDX, through its compound safety screening division Stemina Biomarker Discovery, has developed the leading metabolomics platform for identifying differences in metabolism in …See details»
Marc Schneebaum - Director at NeuroPointDX - The Org
Mr. Schneebaum brings over 25 years of experience in the biotechnology and healthcare sector to Stemina. Most recently, he has served as a consultant in the healthcare industry. From 2011 …See details»
About Our Autism Blood Tests for Kids
The NeuroPointDX Autism Spectrum Disorder (NPDX ASD) blood test is a new tool to help children and families affected by ASD get an earlier diagnosis. Our tests measure metabolites in blood and compares them to the signature …See details»
NeuroPointDX - YouTube
Our first-generation tool, the NeuroPointDX Autism Spectrum Disorder (NPDX ASD) blood test, assists with the diagnosis of autism spectrum disorder.See details»
NeuroPointDX's blood test for Autism Spectrum Disorder: a
Jan 12, 2019 · NeuroPointDX (NPDX), a Madison-based biomedical company, is developing blood tests for early diagnosis of Autism Spectrum Disorder (ASD). According to their …See details»
NeuroPointDX, looking for earlier diagnosis, launches autism …
Nov 1, 2018 · NeuroPointDX has launched what it says is the first objective blood test set up to help diagnose children with autism spectrum disorder earlier, which could help with quicker …See details»
NeuroPointDX Announces Commercialization of First Objective …
Nov 1, 2018 · NeuroPointDX, a division of Stemina Biomarker Discovery, is bringing a precision medicine approach to the diagnosis and treatment of neurological disorders through the …See details»
FAQs About Our Autism Test for Providers | NeuroPointDX.com
NeuroPointDX can identify a subset of children who are likely to receive an ASD diagnosis based on their metabolic signature. By measuring the levels of certain amines and metabolites, and …See details»
NeuroPointDX | Madison WI - Facebook
NeuroPointDX, Madison, Wisconsin. 424 likes. A more precise diagnosis of neuro-developmental disorders is possible. NeuroPointDX's blood test will.See details»
Helping children access earlier treatment and intervention
WHAT IS THE NPDX ASD TEST? A new diagnostic tool to help children and families affected by autism spectrum disorder (ASD) that may lead to an earlier diagnosis for children with ASD. …See details»
NeuroPointDx Commercializes Objective Blood Test for Earlier …
Jan 10, 2019 · NeuroPointDx, Madison, Wis, a division of Stemina Biomarker Discovery, recently announced the commercial launch of its NPDX AA test, which identifies metabolic subtypes …See details»
FAQs About Our Autism Test for Parents | NeuroPointDX.com
NeuroPointDX can identify a subset of children who are likely to receive an ASD diagnosis based on their metabolic signature. By measuring the levels of certain amines and metabolites, and …See details»